Antiserum Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 163 Category: Pharma & Healthcare Report Code : HC0316712
Antiserum Market by Type (Antitoxin Serum, Antiviral Serum, Antibacterial Serum, Anti-Rh Serum) Application (Laboratory, Clinical) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Antiserum Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Antiserum is a type of blood serum that contains monoclonal or polyclonal antibodies and is used to spread passive immunity against a variety of diseases.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users).
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Charles River
- BD
- FUJIFILM Wako Pure Chemical Corporation
- SSI Diagnostica
- GD Animal Health
- OriGene Technologies
- Novacyt Group
- Bethyl Laboratories
- Thermo Scientific
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Antiserum Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Antitoxin Serum
o Antiviral Serum
o Antibacterial Serum
o Anti-Rh Serum
· Antiserum Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Laboratory
o Clinical
· Antiserum Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Charles River
o BD
o FUJIFILM Wako Pure Chemical Corporation
o SSI Diagnostica
o GD Animal Health
o OriGene Technologies
o Novacyt Group
o Bethyl Laboratories
o Thermo Scientific
· Antiserum Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Antiserum Market, By Country
o U.S. Antiserum Market
o Canada Antiserum Market
o Mexico Antiserum Market
o Europe
§ Europe Antiserum Market, By Country
· Germany Antiserum Market
o UK Antiserum Market
o France Antiserum Market
o Russia Antiserum Market
o Italy Antiserum Market
o Rest of Europe Antiserum Market
o Asia-Pacific
§ Asia-Pacific Antiserum Market, By Country
o China Antiserum Market
o Japan Antiserum Market
o South Korea Antiserum Market
o India Antiserum Market
o Southeast Asia Antiserum Market
o Rest of Asia-Pacific Antiserum Market
o South America
§ South America Antiserum Market
o Brazil Antiserum Market
o Argentina Antiserum Market
o Columbia Antiserum Market
o Rest of South America Antiserum Market
o Middle East and Africa
§ Middle East and Africa Antiserum Market
o Saudi Arabia Antiserum Market
o UAE Antiserum Market
o Egypt Antiserum Market
o Nigeria Antiserum Market
o South Africa Antiserum Market
o Rest of MEA Antiserum Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antiserum Market, By Type
5.1. Introduction
5.2. Global Antiserum Revenue and Market Share by Type (2017-2021)
5.2.1. Global Antiserum Revenue and Revenue Share by Type (2017-2021)
5.3. Antitoxin Serum
5.3.1. Global Antitoxin Serum Revenue and Growth Rate (2017-2021)
5.4. Antiviral Serum
5.4.1. Global Antiviral Serum Revenue and Growth Rate (2017-2021)
5.5. Antibacterial Serum
5.5.1. Global Antibacterial Serum Revenue and Growth Rate (2017-2021)
5.6. Anti-Rh Serum
5.6.1. Global Anti-Rh Serum Revenue and Growth Rate (2017-2021)
6. Antiserum Market, By Application
6.1. Introduction
6.2. Global Antiserum Revenue and Market Share by Application (2017-2021)
6.2.1. Global Antiserum Revenue and Revenue Share by Application (2017-2021)
6.3. Laboratory
6.3.1. Global Laboratory Revenue and Growth Rate (2017-2021)
6.4. Clinical
6.4.1. Global Clinical Revenue and Growth Rate (2017-2021)
7. Antiserum Market, By Region
7.1. Introduction
7.2. Global Antiserum Revenue and Market Share by Regions
7.2.1. Global Antiserum Revenue by Regions (2017-2021)
7.3. North America Antiserum by Countries
7.3.1. North America Antiserum Revenue and Growth Rate (2017-2021)
7.3.2. North America Antiserum Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Antiserum by Countries
7.4.1. Europe Antiserum Revenue and Growth Rate (2017-2021)
7.4.2. Europe Antiserum Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Antiserum by Countries
7.5.1. Asia-Pacific Antiserum Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Antiserum Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Antiserum by Countries
7.6.1. South America Antiserum Revenue and Growth Rate (2017-2021)
7.6.2. South America Antiserum Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Antiserum by Countries
7.7.1. Middle East and Africa Antiserum Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Antiserum Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Antiserum Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Charles River
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. BD
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. FUJIFILM Wako Pure Chemical Corporation
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. SSI Diagnostica
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. GD Animal Health
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. OriGene Technologies
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Novacyt Group
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Bethyl Laboratories
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Thermo Scientific
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Antiserum Market Forecast (2022-2027)
9.1. Global Antiserum Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Antiserum Market Forecast by Regions (2022-2027)
9.2.1. North America Antiserum Market Forecast (2022-2027)
9.2.1.1. United States Antiserum Market Forecast (2022-2027)
9.2.1.2. Canada Antiserum Market Forecast (2022-2027)
9.2.1.3. Mexico Antiserum Market Forecast (2022-2027)
9.2.2. Europe Antiserum Market Forecast (2022-2027)
9.2.2.1. Germany Antiserum Market Forecast (2022-2027)
9.2.2.2. France Antiserum Market Forecast (2022-2027)
9.2.2.3. UK Antiserum Market Forecast (2022-2027)
9.2.2.4. Russia Antiserum Market Forecast (2022-2027)
9.2.2.5. Italy Antiserum Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Antiserum Market Forecast (2022-2027)
9.2.3. Asia-Pacific Antiserum Market Forecast (2022-2027)
9.2.3.1. China Antiserum Market Forecast (2022-2027)
9.2.3.2. Japan Antiserum Market Forecast (2022-2027)
9.2.3.3. Korea Antiserum Market Forecast (2022-2027)
9.2.3.4. India Antiserum Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Antiserum Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Antiserum Market Forecast (2022-2027)
9.2.4. South America Antiserum Market Forecast (2022-2027)
9.2.4.1. Brazil Antiserum Market Forecast (2022-2027)
9.2.4.2. Argentina Antiserum Market Forecast (2022-2027)
9.2.4.3. Columbia Antiserum Market Forecast (2022-2027)
9.2.4.4. Rest of South America Antiserum Market Forecast (2022-2027)
9.2.5. Middle East and Africa Antiserum Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Antiserum Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Antiserum Market Forecast (2022-2027)
9.2.5.3. Egypt Antiserum Market Forecast (2022-2027)
9.2.5.4. Nigeria Antiserum Market Forecast (2022-2027)
9.2.5.5. South Africa Antiserum Market Forecast (2022-2027)
9.2.5.6. Turkey Antiserum Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Antiserum Market Forecast (2022-2027)
9.3. Antiserum Market Forecast by Type (2022-2027)
9.3.1. Antiserum Forecast by Type (2022-2027)
9.3.2. Antiserum Market Share Forecast by Type (2022-2027)
9.4. Antiserum Market Forecast by Application (2022-2027)
9.4.1. Antiserum Forecast by Application (2022-2027)
9.4.2. Antiserum Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Antiserum Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Antiserum Revenue and Revenue Share by Type (2017-2019)
Figure Global Antitoxin Serum Revenue and Growth Rate (2017-2019)
Figure Global Antiviral Serum Revenue and Growth Rate (2017-2019)
Figure Global Antibacterial Serum Revenue and Growth Rate (2017-2019)
Figure Global Anti-Rh Serum Revenue and Growth Rate (2017-2019)
Table Global Antiserum Revenue and Revenue Share by Application (2017-2019)
Figure Global Laboratory Revenue and Growth Rate (2017-2019)
Figure Global Clinical Revenue and Growth Rate (2017-2019)
Table Global Antiserum Revenue by Regions (2017-2019)
Figure North America Antiserum Growth Rate (2017-2019)
Figure North America Antiserum Revenue and Growth Rate (2017-2019)
Figure North America Antiserum by Countries (2017-2019)
Figure North America Antiserum Revenue (Million USD) by Countries (2017-2019)
Figure United States Antiserum Growth Rate (2017-2019)
Figure United States Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Antiserum Growth Rate (2017-2019)
Figure Canada Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Antiserum Growth Rate (2017-2019)
Figure Mexico Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Antiserum Growth Rate (2017-2019)
Figure Europe Antiserum Revenue and Growth Rate (2017-2019)
Figure Europe Antiserum by Countries (2017-2019)
Figure Europe Antiserum Revenue (Million USD) by Countries (2017-2019)
Figure Germany Antiserum Growth Rate (2017-2019)
Figure Germany Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Antiserum Growth Rate (2017-2019)
Figure France Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Antiserum Growth Rate (2017-2019)
Figure UK Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Antiserum Growth Rate (2017-2019)
Figure Russia Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Antiserum Growth Rate (2017-2019)
Figure Italy Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Antiserum Growth Rate (2017-2019)
Figure Rest of Europe Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Antiserum Growth Rate (2017-2019)
Figure Asia-Pacific Antiserum Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Antiserum by Countries (2017-2019)
Figure Asia-Pacific Antiserum Revenue (Million USD) by Countries (2017-2019)
Figure China Antiserum Growth Rate (2017-2019)
Figure China Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Antiserum Growth Rate (2017-2019)
Figure Japan Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Antiserum Growth Rate (2017-2019)
Figure Korea Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Antiserum Growth Rate (2017-2019)
Figure India Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Antiserum Growth Rate (2017-2019)
Figure Southeast Asia Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antiserum Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Antiserum Growth Rate (2017-2019)
Figure South America Antiserum Revenue and Growth Rate (2017-2019)
Figure South America Antiserum by Countries (2017-2019)
Figure South America Antiserum Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Antiserum Growth Rate (2017-2019)
Figure Brazil Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Antiserum Growth Rate (2017-2019)
Figure Argentina Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Antiserum Growth Rate (2017-2019)
Figure Columbia Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Antiserum Growth Rate (2017-2019)
Figure Rest of South America Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Antiserum Growth Rate (2017-2019)
Figure Middle East and Africa Antiserum Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Antiserum by Countries (2017-2019)
Figure Middle East and Africa Antiserum Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Antiserum Growth Rate (2017-2019)
Figure Saudi Arabia Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Antiserum Growth Rate (2017-2019)
Figure United Arab Emirates Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Antiserum Growth Rate (2017-2019)
Figure Egypt Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Antiserum Growth Rate (2017-2019)
Figure Nigeria Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Antiserum Growth Rate (2017-2019)
Figure South Africa Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Antiserum Growth Rate (2017-2019)
Figure Turkey Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antiserum Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antiserum Revenue (Millions USD) and Growth Rate (2017-2019)
Table Charles River Antiserum Financial Overview
Table BD Antiserum Financial Overview
Table FUJIFILM Wako Pure Chemical Corporation Antiserum Financial Overview
Table SSI Diagnostica Antiserum Financial Overview
Table GD Animal Health Antiserum Financial Overview
Table OriGene Technologies Antiserum Financial Overview
Table Novacyt Group Antiserum Financial Overview
Table Bethyl Laboratories Antiserum Financial Overview
Table Thermo Scientific Antiserum Financial Overview
Figure Global Antiserum Revenue (Millions USD) and Growth Rate (2019-2027)
Table Antiserum Market Forecast by Regions (2019-2027)
Figure North America Antiserum Market Forecast (2019-2027)
Figure United States Antiserum Market Forecast (2019-2027)
Figure Canada Antiserum Market Forecast (2019-2027)
Figure Mexico Antiserum Market Forecast (2019-2027)
Figure Europe Antiserum Market Forecast (2019-2027)
Figure Germany Antiserum Market Forecast (2019-2027)
Figure France Antiserum Market Forecast (2019-2027)
Figure UK Antiserum Market Forecast (2019-2027)
Figure Russia Antiserum Market Forecast (2019-2027)
Figure Italy Antiserum Market Forecast (2019-2027)
Figure Rest of Europe Antiserum Market Forecast (2019-2027)
Figure Asia-Pacific Antiserum Market Forecast (2019-2027)
Figure China Antiserum Market Forecast (2019-2027)
Figure Japan Antiserum Market Forecast (2019-2027)
Figure Korea Antiserum Market Forecast (2019-2027)
Figure India Antiserum Market Forecast (2019-2027)
Figure Southeast Asia Antiserum Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Antiserum Market Forecast (2019-2027)
Figure South America Antiserum Market Forecast (2019-2027)
Figure Brazil Antiserum Market Forecast (2019-2027)
Figure Argentina Antiserum Market Forecast (2019-2027)
Figure Columbia Antiserum Market Forecast (2019-2027)
Figure Rest of South America Antiserum Market Forecast (2019-2027)
Figure Middle East and Africa Antiserum Market Forecast (2019-2027)
Figure Saudi Arabia Antiserum Market Forecast (2019-2027)
Figure United Arab Emirates Antiserum Market Forecast (2019-2027)
Figure Egypt Antiserum Market Forecast (2019-2027)
Figure Nigeria Antiserum Market Forecast (2019-2027)
Figure South Africa Antiserum Market Forecast (2019-2027)
Figure Turkey Antiserum Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Antiserum Market Forecast (2019-2027)
Figure Global Antiserum Forecast by Type (2019-2027)
Figure Global Antiserum Market Share Forecast by Type (2019-2027)
Figure Global Antiserum Forecast by Type (2019-2027)
Figure Global Antiserum Forecast by Application (2019-2027)
Figure Global Antiserum Market Share Forecast by Application (2019-2027)
Figure Global Antiserum Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|